• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口腔微生物群组成对普通人群中代谢功能障碍相关脂肪性肝病的影响。

Effect of Oral Microbiota Composition on Metabolic Dysfunction-Associated Steatotic Liver Disease in the General Population.

作者信息

Sato Satoshi, Iino Chikara, Furusawa Keisuke, Yoshida Kenta, Chinda Daisuke, Sawada Kaori, Mikami Tatsuya, Nakaji Shigeyuki, Fukuda Shinsaku, Sakuraba Hirotake

机构信息

Department of Gastroenterology, Hematology, and Clinical Immunology, Hirosaki University Graduate School of Medicine, Hirosaki 036-8562, Japan.

Division of Endoscopy, Hirosaki University Graduate School of Medicine, Hirosaki 036-8562, Japan.

出版信息

J Clin Med. 2025 Mar 16;14(6):2013. doi: 10.3390/jcm14062013.

DOI:10.3390/jcm14062013
PMID:40142822
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11943242/
Abstract

This study investigated the relationship between the composition of oral microbiota and metabolic dysfunction-associated steatotic liver disease (MASLD) in the general population. In total, 712 participants in a health check-up project were divided into four oral microbiota patterns by principal component analysis and cluster analysis; they were included in , , , and groups. The group had the largest number of patients and was used as a reference group to compare the incidence of MASLD and cardiometabolic criteria with the other groups. In a multivariate analysis, the group was a risk factor for MASLD independent of cardiometabolic criteria compared with the group. The correlation between oral bacterial species and MASLD-related items showed that was negatively correlated with controlled attenuation parameters, body mass index, waist circumference, hemoglobin A1c, alanine aminotransferase, and fatty liver index. showed a positive correlation with controlled attenuation parameters, waist circumference, body mass index, blood pressure, triglycerides, alanine aminotransferase, aspartate aminotransferase, gamma-glutamyl transpeptidase, and fatty liver index, and a negative correlation with high-density lipoprotein cholesterol. In contrast, the and groups were not clearly associated with MASLD. Maintaining oral hygiene and preventing periodontitis may contribute to preventing MASLD and extending a healthy lifespan.

摘要

本研究调查了普通人群口腔微生物群组成与代谢功能障碍相关脂肪性肝病(MASLD)之间的关系。在一项健康检查项目中,共有712名参与者通过主成分分析和聚类分析被分为四种口腔微生物群模式;他们被纳入A、B、C和D组。A组患者数量最多,被用作参考组,以比较其他组的MASLD发病率和心脏代谢标准。在多变量分析中,与A组相比,C组是独立于心脏代谢标准的MASLD危险因素。口腔细菌种类与MASLD相关指标之间的相关性表明,D与受控衰减参数、体重指数、腰围、糖化血红蛋白、丙氨酸氨基转移酶和脂肪肝指数呈负相关。C与受控衰减参数、腰围、体重指数、血压、甘油三酯、丙氨酸氨基转移酶、天冬氨酸氨基转移酶、γ-谷氨酰转肽酶和脂肪肝指数呈正相关,与高密度脂蛋白胆固醇呈负相关。相比之下,B组和D组与MASLD没有明显关联。保持口腔卫生和预防牙周炎可能有助于预防MASLD并延长健康寿命。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c96b/11943242/2b1f50597298/jcm-14-02013-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c96b/11943242/866e97980dec/jcm-14-02013-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c96b/11943242/2b1f50597298/jcm-14-02013-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c96b/11943242/866e97980dec/jcm-14-02013-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c96b/11943242/2b1f50597298/jcm-14-02013-g002.jpg

相似文献

1
Effect of Oral Microbiota Composition on Metabolic Dysfunction-Associated Steatotic Liver Disease in the General Population.口腔微生物群组成对普通人群中代谢功能障碍相关脂肪性肝病的影响。
J Clin Med. 2025 Mar 16;14(6):2013. doi: 10.3390/jcm14062013.
2
Visceral Adiposity, Anthropometric and Liver Function Indexes for Identifying Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) in Adolescents with Obesity: Which Performs Better?用于识别肥胖青少年代谢功能障碍相关脂肪性肝病(MASLD)的内脏脂肪、人体测量指标和肝功能指标:哪种表现更佳?
J Clin Med. 2025 Mar 19;14(6):2085. doi: 10.3390/jcm14062085.
3
Metabolic dysfunction-associated steatotic liver disease is associated with worse time in ranges in type 1 diabetes.代谢功能障碍相关脂肪性肝病与 1 型糖尿病患者时间范围内的转归较差相关。
Diabetes Obes Metab. 2024 Sep;26(9):3781-3790. doi: 10.1111/dom.15723. Epub 2024 Jun 25.
4
Association between serum uric acid-to-high-density lipoprotein cholesterol ratio and metabolic dysfunction-associated steatotic liver disease among Chinese children with obesity.中国肥胖儿童血清尿酸与高密度脂蛋白胆固醇比值与代谢功能障碍相关脂肪性肝病的关系
Front Endocrinol (Lausanne). 2025 Jan 8;15:1474384. doi: 10.3389/fendo.2024.1474384. eCollection 2024.
5
Associations between cardiometabolic indices and the onset of metabolic dysfunction-associated steatotic liver disease as well as its progression to liver fibrosis: a cohort study.心脏代谢指标与代谢功能障碍相关脂肪性肝病的发病及其向肝纤维化进展之间的关联:一项队列研究
Cardiovasc Diabetol. 2025 Apr 3;24(1):154. doi: 10.1186/s12933-025-02716-6.
6
Prevalence of Transaminitis and Metabolic Dysfunction-Associated Steatotic Liver Disease Among Young Indian Adults-A Population-Based Study.印度年轻成年人中转氨酶升高及代谢功能障碍相关脂肪性肝病的患病率——一项基于人群的研究
J Clin Exp Hepatol. 2025 May-Jun;15(3):102466. doi: 10.1016/j.jceh.2024.102466. Epub 2024 Nov 28.
7
Gender Differences in Liver Steatosis and Fibrosis in Overweight and Obese Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease before and after 8 Weeks of Very Low-Calorie Ketogenic Diet.超重和肥胖代谢功能障碍相关脂肪性肝病患者极低卡路里生酮饮食 8 周前后肝脂肪变性和纤维化的性别差异。
Nutrients. 2024 May 8;16(10):1408. doi: 10.3390/nu16101408.
8
The predictive value of triglyceride-glucose-high density lipoprotein-body mass index (TGH-BMI) for different degrees of hepatic steatosis and liver fibrosis in metabolic dysfunction-associated steatotic liver disease (MASLD).甘油三酯-葡萄糖-高密度脂蛋白-体重指数(TGH-BMI)对代谢功能障碍相关脂肪性肝病(MASLD)不同程度肝脂肪变性和肝纤维化的预测价值
Clin Nutr ESPEN. 2025 Apr;66:290-301. doi: 10.1016/j.clnesp.2025.01.041. Epub 2025 Jan 24.
9
Predicting hepatic steatosis degree in metabolic dysfunction-associated steatotic liver disease using obesity and lipid-related indices.利用肥胖和脂质相关指标预测代谢功能障碍相关脂肪性肝病的肝脂肪变性程度
Sci Rep. 2025 Mar 12;15(1):8612. doi: 10.1038/s41598-024-73132-1.
10
Weight-adjusted waist index is positively and linearly associated with all-cause and cardiovascular mortality in metabolic dysfunction-associated steatotic liver disease: findings from NHANES 1999-2018.体重调整腰围指数与代谢功能障碍相关脂肪性肝病患者的全因和心血管死亡率呈正线性相关:来自 NHANES 1999-2018 的研究结果。
Front Endocrinol (Lausanne). 2024 Sep 30;15:1457869. doi: 10.3389/fendo.2024.1457869. eCollection 2024.

引用本文的文献

1
A Systemic Perspective of the Link Between Microbiota and Cardiac Health: A Literature Review.微生物群与心脏健康关联的系统视角:文献综述
Life (Basel). 2025 Aug 7;15(8):1251. doi: 10.3390/life15081251.

本文引用的文献

1
Metabolic Dysfunction-Associated Steatotic Liver Disease and the Risk of Chronic Periodontitis: A Nationwide Cohort Study.代谢功能障碍相关脂肪性肝病与慢性牙周炎风险:一项全国性队列研究
Nutrients. 2024 Dec 31;17(1):125. doi: 10.3390/nu17010125.
2
Characteristics of intestinal flora in nonobese nonalcoholic fatty liver disease patients and the impact of ursodeoxycholic acid treatment on these features.非肥胖非酒精性脂肪性肝病患者肠道菌群特征及熊去氧胆酸对这些特征的影响。
Lipids. 2024 Nov;59(6):193-207. doi: 10.1002/lipd.12410. Epub 2024 Sep 9.
3
Metabolic dysfunction-associated steatotic liver disease and atherosclerosis.
代谢相关脂肪性肝病与动脉粥样硬化
Curr Diab Rep. 2024 Jul;24(7):158-166. doi: 10.1007/s11892-024-01542-6. Epub 2024 May 3.
4
From gut to liver: unveiling the differences of intestinal microbiota in NAFL and NASH patients.从肠道到肝脏:揭示非酒精性脂肪性肝病(NAFL)和非酒精性脂肪性肝炎(NASH)患者肠道微生物群的差异
Front Microbiol. 2024 Apr 4;15:1366744. doi: 10.3389/fmicb.2024.1366744. eCollection 2024.
5
Association between gut microbiota and NAFLD/NASH: a bidirectional two-sample Mendelian randomization study.肠道微生物群与 NAFLD/NASH 的关联:一项双向两样本 Mendelian 随机研究。
Front Cell Infect Microbiol. 2023 Dec 1;13:1294826. doi: 10.3389/fcimb.2023.1294826. eCollection 2023.
6
Oral Pathogenic Bacteria and the Oral-Gut-Liver Axis: A New Understanding of Chronic Liver Diseases.口腔致病细菌与口腔-肠道-肝脏轴:对慢性肝病的新认识
Diagnostics (Basel). 2023 Oct 26;13(21):3324. doi: 10.3390/diagnostics13213324.
7
The role of microbiome in the pathogenesis of oral-gut-liver axis between periodontitis and nonalcoholic fatty liver disease.微生物群落在牙周炎与非酒精性脂肪性肝病之间的口腔-肠道-肝脏轴发病机制中的作用。
J Dent Sci. 2023 Jul;18(3):972-975. doi: 10.1016/j.jds.2023.03.012. Epub 2023 Mar 25.
8
A multisociety Delphi consensus statement on new fatty liver disease nomenclature.多学会专家共识:新的非酒精性脂肪性肝病命名。
Hepatology. 2023 Dec 1;78(6):1966-1986. doi: 10.1097/HEP.0000000000000520. Epub 2023 Jun 24.
9
Oral microbiota and liver diseases.口腔微生物群与肝脏疾病
Clin Nutr ESPEN. 2023 Apr;54:68-72. doi: 10.1016/j.clnesp.2022.12.030. Epub 2023 Jan 5.
10
Ecological shifts of salivary microbiota associated with metabolic-associated fatty liver disease.与代谢相关脂肪性肝病相关的唾液微生物群落的生态转变。
Front Cell Infect Microbiol. 2023 Feb 14;13:1131255. doi: 10.3389/fcimb.2023.1131255. eCollection 2023.